Use of Thrombopoietin Receptor Agonists in Prolonged Thrombocytopenia after Hematopoietic Stem Cell Transplantation
Open Access
- 9 December 2019
- journal article
- review article
- Published by Elsevier BV in Transplantation and Cellular Therapy
- Vol. 26 (3), e65-e73
- https://doi.org/10.1016/j.bbmt.2019.12.003
Abstract
No abstract availableKeywords
This publication has 76 references indexed in Scilit:
- Indications for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines from the American Society for Blood and Marrow TransplantationTransplantation and Cellular Therapy, 2015
- Significantly worse survival of patients with NIH-defined chronic graft-versus-host disease and thrombocytopenia or progressive onset type: results of a prospective studyLeukemia, 2011
- Prolonged thrombocytopenia after allogeneic hematopoietic stem cell transplantation: associations with impaired platelet production and increased platelet turnoverBone Marrow Transplantation, 2006
- Prognostic importance of the platelet count 100 days post allogeneic bone marrow transplantBone Marrow Transplantation, 2003
- Chronic graft-versus-host disease: A prospective cohort studyTransplantation and Cellular Therapy, 2003
- Secondary failure of platelet recovery after hematopoietic stem cell transplantationTransplantation and Cellular Therapy, 2001
- The Problem of Thrombocytopenia after Hematopoietic Stem Cell TransplantationThe Oncologist, 1996
- A putative truncated cytokine receptor gene transduced by the myeloproliferative leukemia virus immortalizes hematopoietic progenitorsCell, 1990
- Prednisone and azathioprine compared with prednisone and placebo for treatment of chronic graft-v-host disease: prognostic influence of prolonged thrombocytopenia after allogeneic marrow transplantationBlood, 1988
- Isolated thrombocytopenia after allogeneic bone marrow transplantation: existence of transient and chronic thrombocytopenic syndromesBlood, 1985